Affiliated with a Castle Connolly Top Hospital
Who is Dr. Miklos, Hematologist in Stanford, CA?
Dr. David Miklos, MD is a Hematologist, who primarily practices in Stanford, CA with 2 additional practice locations. He is board certified. Dr. Miklos graduated from Yale University School of Medicine and completed his residency at Brigham and Women's Hospital Harvard Medical School. Dr. Miklos is fluent in English, and is currently seeing new patients. Dr. Miklos’s practice accepts Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Miklos’s office at (650) 723-4000.
Where did Dr. Miklos go to medical school and complete their residency?
Fellowship: Dana Farber Cancer Institute
Residency: Brigham and Women's Hospital Harvard Medical School | Brigham & Women's Hospital Program
Medical School: Yale University School of Medicine
What languages does Dr. Miklos speak?
Dr. Miklos and their clinical team can communicate with patients in the following languages:
English
What conditions does Dr. Miklos treat?
As a Hematologist, Dr. Miklos diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Miklos. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Diffuse Large B-cell Lymphoma
- Mantle Cell Lymphoma
- Primary Central Nervous System Lymphoma
- Non-Hodgkin Lymphoma
- Lymphoma
- DLBCL
- Large B-cell Lymphoma
- Aggressive B-cell Lymphoma
- Diffuse B-cell Lymphoma
- MCL
- Mantle Zone Lymphoma
- Intermediate Lymphoma
- Mantle Cell Lymphoma Cancer
- PCNSL
- Brain Lymphoma
- Spinal Cord Lymphoma
- CNS Lymphoma
- Lymphatic Cancer
- Lymphoma in Organs
- NHL
ICD-10 Codes:
- C8333: Diffuse large B-cell lymphoma, intra-abdominal lymph nodes
- C8330: Diffuse large B-cell lymphoma, unspecified site
- C8338: Diffuse large B-cell lymphoma, lymph nodes of multiple sites
- C8313: Mantle cell lymphoma, intra-abdominal lymph nodes
- C8331: Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
- C8310: Mantle cell lymphoma, unspecified site
- C8332: Diffuse large B-cell lymphoma, intrathoracic lymph nodes
- C8339: Diffuse large B-cell lymphoma, extranodal and solid organ sites
- C8335: Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb
- C8318: Mantle cell lymphoma, lymph nodes of multiple sites
- C83390: Primary central nervous system lymphoma
- C8589: Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites
Also known as:
- Acute Myeloid Leukemia in Remission
- Acute Lymphocytic Leukemia in Remission
- Chronic Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia Treatment (PDQ®)
- AML Leukemia in Remission
- Acute Myeloblastic Leukemia in Remission
- Acute Myelogenous Leukemia in Remission
- ALL Leukemia in Remission
- Acute Lymphoblastic Leukemia in Remission
- Childhood Leukemia in Remission
- CLL
- B-cell chronic lymphocytic leukemia
- Lymphocytic leukemia
ICD-10 Codes:
- C9201: Acute myeloblastic leukemia, in remission
- C9101: Acute lymphoblastic leukemia, in remission
- C9110: Chronic lymphocytic leukemia of B-cell type not having achieved remission
Also known as:
- Multiple Myeloma
- Multiple Myeloma in Remission
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ)
- Active multiple myeloma
- Untreated multiple myeloma
- Plasma cell myeloma
- Plasma Cell Myeloma in Remission', 'Kahler's Disease in Remission
- Myeloma in Remission
ICD-10 Codes:
- C9000: Multiple myeloma not having achieved remission
- C9001: Multiple myeloma in remission
Also known as:
- Myelodysplastic Syndrome
- Myelodysplastic Syndromes
- Myelodysplastic Syndromes Treatment (PDQ®)
- MDS
- Preleukemia
- Bone marrow failure disorder
ICD-10 Codes:
- D469: Myelodysplastic syndrome, unspecified
Also known as:
- Bone Marrow Transplant
- Bone Marrow Transplantation
- Stem Cell Transplant
- Hematopoietic Stem Cell Transplant
- Marrow Transplant
ICD-10 Codes:
- Z9481: Bone marrow transplant status
Also known as:
- History of Other Medical Treatment
- Past Medical Procedures
- Previous Medical Care
- History of Past Treatments
ICD-10 Codes:
- Z9289: Personal history of other medical treatment
Which procedures does Dr. Miklos perform as a Hematologist?
As a Hematologist, procedures performed by a Dr. David Miklos may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Miklos' office.
Does Dr. Miklos accept my insurance?
Dr. Miklos accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Miklos accept in Stanford, CA?
Dr. Miklos in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Central California Alliance for Health
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
OptumRx
UnitedHealthcare
Valley Health Plan
View All Insurances
Where is Dr. Miklos' office located?
Recognitions
Publications
A distinct evolution of the T
BLOOD, 2013
H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2013
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2011
Measurement and Clinical Monitoring of Human Lymphocyte Clolity by Massively Parallel V-D
SCIENCE TRANSLATIOL MEDICINE, 2009
Birth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013
Clolly identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL
BONE MARROW TRANSPLANTATION, 2011
The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011
B cells promote insulin resistance through modulation of T cells
TURE MEDICINE, 2011
Long-term outcomes in patients with high
BONE MARROW TRANSPLANTATION, 2011
Recombint antigen microarrays for serum/plasma antibody detection.
Methods in molecular biology (Clifton, N.J.), 2011
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular
BRITISH JOURL OF HAEMATOLOGY, 2010
Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.
Proceedings of the tiol Academy of Sciences of the United States of Am, 2010
Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene
JOURL OF IMMUNOLOGY, 2010
Identifying compartment-specific non
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2009
B Cells and Transplantation: An Educatiol Resource
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009
Rel pathology in hematopoietic cell transplantation recipients
MODERN PATHOLOGY, 2008
Toward biomarkers for chronic graft-versus-host disease
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006
Minimal residual disease quantification using consensus primers
LEUKEMIA, 2013
A distinct evolution of the T
BLOOD, 2013
H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2013
Massive evolution of the immunoglobulin heavy chain locus
BLOOD, 2012
Prophylactic rituximab after allogeneic transplantation decreases B
BLOOD, 2012
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2011
Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D
SCIENCE TRANSLATIONAL MEDICINE, 2009
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft
BLOOD, 2005
Birth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013
Humoral Immunity to Cytomegalovirus and Chronic Graft-Versus-Host Disease
VIRAL IMMUNOLOGY, 2012
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative
BONE MARROW TRANSPLANTATION, 2012
Clonally identical Hodgkin's dise
BONE MARROW TRANSPLANTATION, 2011
Adoptive Immunotherapy with Cytokine
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011
A phase 1 study of imatinib for corticosteroid-dependent
BLOOD, 2011
Combined CD4 T-Cell
TRANSPLANTATION, 2011
The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011
B cells promote insulin resistance through modulation of T cells
NATURE MEDICINE, 2011
Protein Microarrays Discover Angiotensinogen
MOLECULAR & CELLULAR PROTEOMICS, 2011
Long-term outcomes in patients with high
BONE MARROW TRANSPLANTATION, 2011
Recombinant antigen microarrays for serum/plasma antibody detection.
Methods in molecular biology (Clifton, N.J.), 2011
Outcomes of pediatric bone marrow transplantation for leukemia
BLOOD, 2010
H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients
HUMAN REPRODUCTION, 2010
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular
BRITISH JOURNAL OF HAEMATOLOGY, 2010
Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.
Proceedings of the National Academy of Sciences of the United States o, 2010
Phase I/II Trial of GN-BVC
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010
Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene
JOURNAL OF IMMUNOLOGY, 2010
Rituximab in hematopoietic cell transplantation
EXPERT OPINION ON BIOLOGICAL THERAPY, 2010
Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation
BLOOD, 2010
TLI and ATG conditioning with low risk of graft-versus
BLOOD, 2009
Identifying compartment-specific non
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2009
B Cells and Transplantation: An Educational Resource
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009
H-Y antibody development associates with acute rejection in female patients with male kidney
TRANSPLANTATION, 2008
Renal pathology in hematopoietic cell transplantation recipients
MODERN PATHOLOGY, 2008
Rituximab for steroid-refractory chronic graft-versus-host disease
BLOOD, 2006
Toward biomarkers for chronic graft-versus-host disease
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell
BLOOD, 2004
What is Dr. Miklos's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Miklos's National Provider Identifier (NPI) number is 1982751053.
What common questions do patients ask about Dr. Miklos?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Miklos
What is Dr. David Miklos's specialty?
Dr. Miklos is a Hematologist near Stanford, CA. An internist with advanced training specializing in disorders of the blood, spleen, and lymphatic system. This specialist manages conditions such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia, and lymphoma. Contact Dr. Miklos to book an appointment today.
Is this Dr. David Miklos affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Miklos is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Hematologist?
Explore Hematologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is David Miklos accepting new patients in Stanford, CA?
Yes, Dr. David Miklos is accepting new patients at this time.
Does Dr. David Miklos offer online booking?
Please contact Dr. Miklos's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with David Miklos?
Please contact Dr. Miklos's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Other Hematologist Near Stanford, CA
Hematologist
Accepting patientsHematologist
Accepting patientsMedical Oncologist
Accepting patients